Jianwei Tian

Jianwei Tian


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
PDF file
TLTonghua Li
Tonghua Li
YZYuyang Zhang
Yuyang Zhang
JTJianwei Tian
Jianwei Tian
LYLu Yang
Lu Yang
JWJianchang Wang
Jianchang Wang

21 March 2016 in Oncotarget
Verified
Journal Article
Open access
FZFengxin Zhu
Fengxin Zhu
WLWei Liu
Wei Liu
TLTang Li
Tang Li
JWJiao Wan
Jiao Wan
JTJianwei Tian
Jianwei Tian
JNJing Nie
Jing Nie
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Fengxin Zhu1, Wei Liu2, Tang Li3, Jiao Wan1, Jianwei Tian1, Zhanmei Zhou1, Hao Li1, Youhua Liu1, Fan Fan Hou1, Jing Nie1 1State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China 2Department of Nephrology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, P.R. China 3The VIP Medical Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P.R. China Correspondence to: Jing Nie e-mail: niejing@smu.edu.cn Keywords: Numb, G2/M arrest, p53, proximal tubular cells, interstitial fibrosis Received: November 30, 2015 Accepted: March 06, 2016 Published: March 21, 2016

23 May 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
RMRui Ma
Rui Ma
HOHan Ouyang
Han Ouyang
SMShihong Meng
Shihong Meng
JLJun Liu
Jun Liu
JTJianwei Tian
Jianwei Tian
FHFan Fan Hou
Fan Fan Hou
BACKGROUND: Identifying patients with acute kidney injury (AKI) at high risk of chronic kidney disease (CKD) progression remains a challenge. METHODS: Kidney transcriptome sequencing was applied to identify the top upregulated genes in mice with AKI. The product of the top-ranking gene was identified in tubular cells and urine in mouse and human AKI. Two cohorts of patients with prehospitalization estimated glomerular filtration rate (eGFR) ≥ 45 mL/min/1.73 m 2 who survived over 90 days after AKI were used to derive and validate the predictive models. AKI-CKD progression was defined as eGFR < 60 mL/min/1.73 m 2 and with minimum 25% reduction from baseline 90 days after AKI in patients with prehospitalization eGFR ≥ 60 mL/min/1.73 m 2 . AKI-advanced CKD was defined as eGFR < 30 mL/min/1.73 m 2 90 days after AKI in those with prehospitalization eGFR 45–59 mL/min/1.73 m 2 . RESULTS: Kidney cytokeratin 20 (CK20) was upregulated in injured proximal tubular cells and detectable in urine within 7 days after AKI. High concentrations of urinary CK20 (uCK20) were independently associated with the severity of histological AKI and the risk of AKI-CKD progression. In the Test set, the AUC of uCK20 for predicting AKI-CKD was 0.80, outperforming reported biomarkers for predicting AKI. Adding uCK20 to clinical variables improved the ability to predict AKI-CKD progression, with an AUC of 0.90, and improved the risk reclassification. CONCLUSION: These findings highlight uCK20 as a useful predictor for AKI-CKD progression and may provide a tool to identify patients at high risk of CKD following AKI. FUNDING: National Natural Science Foundation of China, National Key R&D Program of China, 111 Plan, Guangdong Key R&D Program

2 May 2023 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
ZXZhiwen Xiao
Zhiwen Xiao
JTJianwei Tian
Jianwei Tian
FZFen Zhang
Fen Zhang
XZXiaohong Zhong
Xiaohong Zhong
TZTingting Zhang
Tingting Zhang
JAJun Ai
Jun Ai
Background. Matrix metalloproteinase-7 (MMP7) is markedly expressed in patients with chronic kidney disease; its expression in dialysate and role in patients undergoing peritoneal dialysis (PD) have not been well established. Methods. Participants undergoing PD from June 1st, 2015, to June 30th, 2020, were involved and were followed up every 3 months for the first year and every 6 months thereafter until death, PD withdrawal, or the end of the study. Data at each follow-up point were collected and analyzed for the association with congestive heart failure (CHF), PD withdrawal, and combined endpoint. Results. A total of 283 participants were included in this study. During a median follow-up of 21 months, 20 (7) participants died, 93 (33) withdrew from PD, and 105 (37) developed CHF. A significantly increased level of serum and dialysate MMP7 was observed at baseline. Dialysate MMP7 presented a good linearity with serum MMP7. Baseline serum and dialysate MMP7 levels were associated with CHF in multivariable Cox proportional hazards regression models. After categorization, participants with high baseline MMP7 levels had a higher incidence of CHF (42), and the hazard ratios (95 confidence intervals) were 1.595 (1.023-2.488). Interestingly, participants with higher serum MMP7 levels were trended to use dialysate with higher glucose concentration. However, the ultrafiltration volumes were not significantly increased. Higher MMP7 levels were also positively associated with PD withdrawal and combined endpoint. Conclusions. The expression of MMP7 in serum and dialysate was markedly increased and was tightly associated with the risk of CHF in PD patients. This finding suggests that the measurement of MMP7 may inform strategies for managing CHF at an earlier stage.

1 January 2026 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
JWJiajian Wang
Jiajian Wang
XLXiaodan Li
Xiaodan Li
YZYurong Zheng
Yurong Zheng
HZHong Zhou
Hong Zhou
LSLicong Su
Licong Su
HZHongyu Zhang
Hongyu Zhang
Background: Venous thromboembolism (VTE), a potentially life‐threatening condition, is a complication associated with various medical procedures. However, limited national data are currently available to comprehensively assess the incidence and risk factors for VTE following maintenance dialysis (MD). This study addresses this gap by investigating the prevalence and potential predictors of VTE in a large, nationally representative database of patients undergoing MD. Methods: We conducted a retrospective analysis of the Nationwide Inpatient Sample (NIS) database for the years 2010–2019. The study population included patients for whom elective MD served as the primary procedure. Logistic regression analysis was employed to evaluate the association between demographic characteristics, pre‐existing medical conditions (comorbidities), and postdialysis complications in MD patients with the occurrence of VTE. Results: Our analysis revealed an overall prevalence of VTE in 34,698 patients undergoing MD, translating to an incidence rate of 2.43%. This study represents the first comprehensive investigation into the incidence and risk factors for VTE following MD. Compared to patients without VTE, those who developed VTE exhibited a higher burden of preoperative comorbidities, extended hospitalization, increased hospital charges, and a significantly higher in‐hospital mortality rate ( p < 0.001). Additionally, VTE following MD was associated with major complications during hospitalization, including thrombocytopenia, acute renal failure, and sepsis. Furthermore, preoperative risk factors independently associated with VTE included acquired immunodeficiency syndrome (AIDS), rheumatoid arthritis, coagulopathy, drug abuse, hypertension, lymphoma, fluid and electrolyte disorders, metastatic cancer, other neurological disorders, paralysis, and solid tumors without metastasis ( p < 0.001). Conclusions: A comprehensive understanding of the risk factors contributing to VTE development following MD is crucial for implementing preventive measures and mitigating associated adverse outcomes.